ROLE SUMMARY
The Director, Health Economics & Outcomes Research (HEOR) Eliquis is responsible for development and execution of high quality HEOR strategic efforts to support optimal reimbursement and access for Eliquis in the US, with a focus on delivering robust evidence demonstrating the clinical and economic value of the product(s), successfully impacting business objectives on a global basis.
As part of the Global HEOR team, the HEOR Director will function with a one-Patient and Health Impact (PHI) mindset and work in a closely aligned fashion with the full team to ensure there is a single and coordinated view on strategy and delivery from PHI to the business. The HEOR Director will be a strategic partner to the US Eliquis matrix team and will work to implement an HEOR strategy that supports the US needs while aligning with a global strategy. This role reports to the Eliquis Integrated Team Lead.
ROLE RESPONSIBILITIES
* Partner with the product / therapeutic area asset teams to develop and execute the US HEOR strategy to support the value of Eliquis in the IM Business Unit.
* Ensure alignment with Alliance Partner and crossfunctional stakeholders for US plan
* Lead the execution of HEOR studies and projects in alignment with the global HEOR strategy to support and enhance the value proposition for the Eliquis. May include some or all of the following:
* Create and maintain value dossiers, evidence blueprints, payer value messages and innovative tools
* Develop and utilize cost-effectiveness, budget impact, and health impact model(s) to communicate the public health and economic value of the asset(s)
* Conduct observational studies (e.g. burden of disease, outcomes research, costing studies, etc.) within non-interventional study processes
* Develop real world evidence generation strategies and execute studies (e.g. treatment patterns, real world effectiveness, burden of illness, costing, epidemiology studies, etc.) within non-interventional study processes
* Generate peer-reviewed publications to communicate study findings in scientific channels in alignment with the product publication strategy
* Assess, synthesize, and interpret relevant literature and communicate findings to internal and external stakeholders
* Support commercialization efforts of HEOR studies, both internal and independent
* Support the development and evaluation of outcomes based agreements
* Execute and manage research projects with external collaborators/vendors to ensure timely completion and quality of deliverables as well as budget/legal compliance
* Responsible for the management of the Eliquis US HEOR budget
* Engage external key opinion leaders (KOLs) for research and insight generation
BASIC QUALIFICATIONS
Candidate demonstrates a breadth of diverse cross functional leadership experiences and capabilities including: the ability to influence and collaborate with peers to achieve meaningful outcomes and create business impact.
* Masters (MSc, MPH) or Doctoral degree (PhD, Dr PH, ScD) in health services research, public health, epidemiology, or health economics
* 8 years of experience in HEOR and relevant related fields
* Demonstrated expert understanding of fundamental health services research methods and tools including but not limited to:
* Health economics
* Cost-effectiveness / budgetary impact modeling
* Prospective and retrospective data analyses
* Patient reported outcomes measures
* Real world evidence studies
* Epidemiology
* Statistics
* Able to independently engage all levels of stakeholders through a strong customer orientation, strategic thinking, leading change, and building collaborative partnerships in a matrix environment
* Demonstrated ability to assess anticipated value for projects/programs to ensure alignment to business priorities and prioritize accordingly
* Demonstrated ability to prioritize time and resources and manage multiple projects (multitask) involving complex processes, significant budget, competing deadlines and rapidly shifting priorities in a compliant manner
* Excellent oral and written English communication skills are required
PREFERRED QUALIFICATIONS
* Knowledge and experience in anticoagulation, atrial fibrillation, and/or venous thromboembolism therapeutic areas
Other Job Details:
Last Date to Apply for Job: March 2nd, 2021
Additional Location Information: New York, NY; Collegeville, PA; US Remote
LI-PFE
Sunshine Act
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care providers name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.
EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.
Market Access
LI-PFE
New York, New York
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases under the Lyrica, Chantix/Champix, Eliquis, Ibrance, Sutent, Xalkori, Inlyta, Xtandi, Enbrel, Xeljanz, Eucrisa, BeneFix, Genotropin, and Refacto AF/Xyntha brands. The company also provides consumer healthcare products that comprise over-the-counter medicines, including dietary supplement products under the Centrum, Caltrate, and Emergen-C names; pain management products under the Advil and ThermaCare names; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H names; and respiratory and personal care products under the Robitussin, Advil Cold & Sinus, and ChapStick names. In addition, it offers products that would lose or have lost marketing patent protection; branded generic products; generic sterile injectable products; biosimilars; and anti-infectives under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, Viagra, Inflectra/Remsima, Zyvox, Vfend, Revatio, Inspra, Medrol, Sulperazon, Fragmin, Tygacil, Nivestim, and Retacrit, Ixifi Infliximab BS names.
Further, the company is also involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., and Oncolytics Biotech Inc.; licensing agreement with BionTech AG; strategic alliance with Verily Life Sciences LLC; and collaboration agreements with Pfizer, Merck & Co., Inc., and Eli Lilly & Company, as well as with Merck KGaA and Nektar Therapeutics to develop a therapy for treating pancreatic cancer. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.